A push by Canada’s licensed medical marijuana producers to release topical balms and creams shows the creativity and ingenuity with which they have navigated the regulations to release novel products to Canadian patients.
Under the Access to Cannabis for Medical Purposes Regulations, licensed producers can only sell fresh or dried marijuana and what the regulations call “cannabis oil.” However, there are a couple of stipulations that LPs face in selling oils. These include the rule dictating that THC in the products must be capped at a total of 30mg per ml. In addition, oil must be in liquid form at room temperature around 22 ± 2°C. Lastly, the ACMPR says the oil must ”contain cannabis in its natural form.”
What do all these requirements add up to? While it’s unclear what the exact rationale behind Health Canada imposing these conditions is, some LPs have figured out how to sell topical balms in a way that appears to adhere to the government’s conditions for “cannabis oil.”
Patients may be used to using non-cannabis topical balms that are much more viscous in nature, than say, water. While that might be a preferred consistency for many, the regulations clearly state that oil must be liquid at room temperature.
The solution? Sell topical balms that are liquid at room temperature but become a cream when placed in the freezer. That’s what Whistler Medical Marijuana did earlier this year when they released their “tangerine topical oil” and “blueberry balm.”
Licensed producer Medreleaf has taken its own approach, this week releasing what they are calling the first topical cream from an LP to hit the market, coming in the more viscous cream form that patients are used to. How did they do it? Well, for starters, Medreleaf’s cream doesn’t actually contain cannabis, as only products containing cannabis are regulated by the ACMPR. Instead, patients are advised to buy from Medreleaf’s existing line of cannabis oil and then mix this in with the non-cannabis cream. Cool, right?
In fact, the ACMPR implies that producers are allowed to sell oil that is meant to be topical in nature where the regulations state that such oil must have a warning label that says it is “for topical use only.”
Will more LPs follow, and come up with ways to release additional product types while still adhering to the ACMPR? You bet they will, and Lift News will be there as it happens to bring readers’ attention to new innovations from the legal medical cannabis sector.
Featured image by Stux.